Clinical Professor University of Rhode Island Kingston, Rhode Island, United States
Anita Jacobson, PharmD: No financial relationships to disclose
Xylazine, levamisole and phenacetin are showing up on the street, but how might they impact harm reduction efforts for patients? What can pharmacists do in the community to overcome barriers to, and facilitate harm reduction? Attend this essential session to learn all of this and more.
Recognize trends in the unregulated drug supply and their implications for patients.
Discuss harm reduction strategies in community pharmacy.
Describe the impact of harm reduction efforts.
Identify ways to overcome barriers to providing tools to promote harm reduction and recovery.